tiprankstipranks
Malachite Innovations (MLCT)
OTHER OTC:MLCT
US Market

Malachite Innovations (MLCT) Stock Price & Analysis

136 Followers

MLCT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.10 - $0.25
Previous Close$0.15
Volume18.29K
Average Volume (3M)10.48K
Market Cap
$13.09M
Enterprise Value$22.37M
Total Cash (Recent Filing)$1.03M
Total Debt (Recent Filing)$10.30M
Price to Earnings (P/E)3.9
Beta-0.71
Nov 14, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding89,690,149
10 Day Avg. Volume26,064
30 Day Avg. Volume10,478
Standard Deviation0.45
R-Squared0.06
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)2.48
Price to Sales (P/S)3.62
Price to Cash Flow (P/CF)2.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.48
Enterprise Value/Gross Profit16.06
Enterprise Value/Ebitda1.57
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

64.87%0.00%0.08%35.05%
64.87% Insiders
0.08% Other Institutional Investors
35.05% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

MLCT FAQ

What was Malachite Innovations’s price range in the past 12 months?
Malachite Innovations lowest stock price was $0.10 and its highest was $0.25 in the past 12 months.
    What is Malachite Innovations’s market cap?
    Currently, no data Available
    When is Malachite Innovations’s upcoming earnings report date?
    Malachite Innovations’s upcoming earnings report date is Nov 14, 2023 which is 173 days ago.
      How were Malachite Innovations’s earnings last quarter?
      Malachite Innovations released its earnings results on Aug 01, 2023. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
        Is Malachite Innovations overvalued?
        According to Wall Street analysts Malachite Innovations’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Malachite Innovations pay dividends?
          Malachite Innovations does not currently pay dividends.
          What is Malachite Innovations’s EPS estimate?
          Malachite Innovations’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Malachite Innovations have?
          Malachite Innovations has 89,690,150 shares outstanding.
            What happened to Malachite Innovations’s price movement after its last earnings report?
            Malachite Innovations reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Malachite Innovations?
              Currently, no hedge funds are holding shares in MLCT
              ---

              Malachite Innovations Stock Smart Score

              Company Description

              Malachite Innovations

              Vitality Biopharma, Inc. engages in unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. It operates through Pharmaceutical Operations and Clinical Operations segments. The Clinical Operations segment focuses on treating patients suffering from addiction and dependency. The Pharmaceutical Operations segment engages in research and development primarily related to the Company's cannabinoid pharmaceuticals. The company was founded by Avtar S. Dhillon and Robert T. Brooke on June 29, 2007 and is headquartered in Los Angeles, CA.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Amazon
              Apple
              Alphabet Class A
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis